Individual patient data meta-analysis of trial of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: Protocol for a systematic review

被引:5
作者
Farmer, A. J. [1 ]
Heneghan, C. [1 ]
Barnett, A. H. [2 ,3 ]
Davidson, M. B. [4 ]
Guerci, B. [5 ,6 ]
O'Kane, M. [7 ]
Schwedes, U. [8 ]
Perera, R. [1 ]
机构
[1] Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Hlth Care, Oxford, England
[2] Univ Birmingham, Dept Med, Birmingham, W Midlands, England
[3] Birmingham Heartlands Hosp, Heart England Natl Hlth Serv Fdn Trust, Birmingham, W Midlands, England
[4] Charles Drew Univ, Clin Ctr Res Excellence, Los Angeles, CA USA
[5] Univ Nancy, Diabetol,Metab Dis & Nutrit, BP 90303, F-54201 Toul, France
[6] CHU, Hosp Jeanne Arc, CIC Inserm, BP 90303, F-54201 Toul, France
[7] Altnagelvin Hosp, Dept Clin Chem, Western Hlth & Social Care Trust, Londonderry, Ireland
[8] Diabet Zentrum Hamburg City, Monckebergstr 5, D-20095 Hamburg, Germany
关键词
Study protocol; Individual patient data; meta-analysis; Self-monitoring of blood glucose; Type; 2; diabetes; PARALLEL-GROUP; MANAGEMENT; MELLITUS; EFFICACY;
D O I
10.1016/j.pcd.2009.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the study: Recent trials have provided differing estimates of the benefits of self-monitoring of blood glucose (SMBG) for non-insulin treated patients with type 2 diabetes. Designing and conducting randomised trials to demonstrate the efficacy of complex interventions is challenging. Variations in the components of the intervention delivered, target population selected, and reporting methods used have limited the conclusions drawn in recent systematic reviews. We will systematically examine these factors within the trials of SMBG to enable further investigation of the data through an individual patient data analysis (IPD). Methods/design: The IPD analysis will include data from randomised trials comparing blood glucose self-monitoring and decisions about self-management versus a control group with standardised or routine care. The data requested for each trial will include outcomes (HbA1c, blood glucose and quality of life), potential moderators of effect (e.g. demographic variables, clinical data and psychosocial factors) and intervention descriptors. The primary outcome of interest will be HbA1c. Secondary outcomes include alternative measures of glycaemia, cardiovascular risk factors, persistence with monitoring, and measures of health status, quality of life and psychosocial factors. Analysis of patient sub-groups defined by age at randomisation, gender, prior use of monitoring and health status will be carried out. An intention to treat analysis will be performed and assessed for clinical and statistical heterogeneity. With current uncertainty about the extent of benefit from SMBG for non-insulin treated patients with type 2 diabetes, this study will provide the best estimates to date of overall effectiveness, effectiveness within potential target populations, and optimal components of the intervention. (C) 2009 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 15 条
[1]   The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study) [J].
Barnett, A. H. ;
Krentz, A. J. ;
Strojek, K. ;
Sieradzki, J. ;
Azizi, F. ;
Embong, M. ;
Imamoglu, S. ;
Perusicova, J. ;
Uliciansky, V. ;
Winkler, G. .
DIABETES OBESITY & METABOLISM, 2008, 10 (12) :1239-1247
[2]   The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: A blinded, randomized trial [J].
Davidson, MB ;
Castellanos, M ;
Kain, D ;
Duran, P .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (04) :422-425
[3]   Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial [J].
Farmer, Andrew ;
Wade, Alisha ;
Goyder, Elizabeth ;
Yudkin, Patricia ;
French, David ;
Craven, Anthea ;
Holman, Rury ;
Kinmonth, Ann-Louise ;
Neil, Andrew .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7611) :132-136
[4]   Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus:: the Auto-Surveillance Intervention Active (ASIA) study [J].
Guerci, B ;
Drouin, P ;
Grangé, V ;
Bougnères, P ;
Fontaine, P ;
Kerlan, V ;
Passa, P ;
Thivolet, C ;
Vialettes, B ;
Charbonnel, B .
DIABETES & METABOLISM, 2003, 29 (06) :587-594
[5]   Self monitoring of blood glucose in type 2 diabetes [J].
Gulliford, Martin .
BRITISH MEDICAL JOURNAL, 2008, 336 (7654) :1139-1140
[6]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560
[7]   Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature [J].
McAndrew, Lisa ;
Schneider, Stephen H. ;
Burns, Edith ;
Leventhal, Howard .
DIABETES EDUCATOR, 2007, 33 (06) :991-1011
[8]   Self-monitoring of blood glucose in type-2 diabetes: what is the evidence? [J].
McGeoch, Grace ;
Derry, Sheena ;
Moore, R. Andrew .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2007, 23 (06) :423-440
[9]   Self-monitoring of blood glucose in insulin-requiring type 2 diabetes [J].
Naik, Ramachandra G. ;
Ellis, Samuel L. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 :S67-S71
[10]  
O'Kane MJ, 2008, BMJ-BRIT MED J, V336, P1174, DOI 10.1136/bmj.39534.571644.BE